BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36757799)

  • 21. The calcium pump PMCA4 prevents epithelial-mesenchymal transition by inhibiting NFATc1-ZEB1 pathway in gastric cancer.
    Wang T; Li N; Jin L; Qi X; Zhang C; Hua D
    Biochim Biophys Acta Mol Cell Res; 2020 Dec; 1867(12):118833. PubMed ID: 32860837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer.
    Zhang J; Guan W; Xu X; Wang F; Li X; Xu G
    Oncogene; 2021 Jul; 40(30):4906-4918. PubMed ID: 34163033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells.
    Siddiqui A; Vazakidou ME; Schwab A; Napoli F; Fernandez-Molina C; Rapa I; Stemmler MP; Volante M; Brabletz T; Ceppi P
    J Pathol; 2017 Jun; 242(2):221-233. PubMed ID: 28337746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer.
    Hanrahan K; O'Neill A; Prencipe M; Bugler J; Murphy L; Fabre A; Puhr M; Culig Z; Murphy K; Watson RW
    Mol Oncol; 2017 Mar; 11(3):251-265. PubMed ID: 28133913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
    Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
    Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of DAPK1 promotes the stemness of cancer stem cells and EMT process by activating ZEB1 in colorectal cancer.
    Yuan W; Ji J; Shu Y; Chen J; Liu S; Wu L; Zhou Z; Liu Z; Tang Q; Zhang X; Shu X
    J Mol Med (Berl); 2019 Jan; 97(1):89-102. PubMed ID: 30460377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-105 promotes epithelial-mesenchymal transition of nonsmall lung cancer cells through upregulating Mcl-1.
    Jin X; Yu Y; Zou Q; Wang M; Cui Y; Xie J; Wang Z
    J Cell Biochem; 2019 Apr; 120(4):5880-5888. PubMed ID: 30317672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73.
    Lu Z; Jiao D; Qiao J; Yang S; Yan M; Cui S; Liu Z
    Mol Cancer; 2015 May; 14():102. PubMed ID: 25972084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity.
    Bota-Rabassedas N; Banerjee P; Niu Y; Cao W; Luo J; Xi Y; Tan X; Sheng K; Ahn YH; Lee S; Parra ER; Rodriguez-Canales J; Albritton J; Weiger M; Liu X; Guo HF; Yu J; Rodriguez BL; Firestone JJA; Mino B; Creighton CJ; Solis LM; Villalobos P; Raso MG; Sazer DW; Gibbons DL; Russell WK; Longmore GD; Wistuba II; Wang J; Chapman HA; Miller JS; Zong C; Kurie JM
    Cell Rep; 2021 Apr; 35(3):109009. PubMed ID: 33882319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Key EMT-Regulating miRNAs Highlight the Role of ZEB1 in EGFR Tyrosine Kinase Inhibitor-Resistant NSCLC.
    Gohlke L; Alahdab A; Oberhofer A; Worf K; Holdenrieder S; Michaelis M; Cinatl J; Ritter CA
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
    Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
    Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Form follows function: Morphological and immunohistological insights into epithelial-mesenchymal transition characteristics of tumor buds.
    Enderle-Ammour K; Bader M; Ahrens TD; Franke K; Timme S; Csanadi A; Hoeppner J; Kulemann B; Maurer J; Reiss P; Schilling O; Keck T; Brabletz T; Stickeler E; Werner M; Wellner UF; Bronsert P
    Tumour Biol; 2017 May; 39(5):1010428317705501. PubMed ID: 28475002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous expression of zinc-finger E-box-binding homeobox 1 plays a pivotal role in metastasis via regulation of miR-200c in epithelial-mesenchymal transition.
    Muto Y; Suzuki K; Kato T; Tsujinaka S; Ichida K; Takayama Y; Fukui T; Kakizawa N; Watanabe F; Saito M; Futsuhara K; Noda H; Miyakura Y; Konishi F; Rikiyama T
    Int J Oncol; 2016 Sep; 49(3):1057-67. PubMed ID: 27315529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
    Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
    Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
    Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
    Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis.
    Peng DH; Ungewiss C; Tong P; Byers LA; Wang J; Canales JR; Villalobos PA; Uraoka N; Mino B; Behrens C; Wistuba II; Han RI; Wanna CA; Fahrenholtz M; Grande-Allen KJ; Creighton CJ; Gibbons DL
    Oncogene; 2017 Apr; 36(14):1925-1938. PubMed ID: 27694892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The transcription factor ZEB1 mediates the progression of epithelial ovarian cancer by promoting the transcription of CircANKRD17.
    Cai W; Zhang Q
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23086. PubMed ID: 35521974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor cell-derived angiopoietin-like protein 2 establishes a preference for glycolytic metabolism in lung cancer cells.
    Osumi H; Horiguchi H; Kadomatsu T; Tashiro K; Morinaga J; Takahashi T; Ikeda K; Ito T; Suzuki M; Endo M; Oike Y
    Cancer Sci; 2020 Apr; 111(4):1241-1253. PubMed ID: 32012400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.